Free Trial
→ Breaking News: Tesla headed to $500… (From WealthPress) (Ad)

Obesity Drug Boom, Split Make This Stock a Heavy Bargain

Written by MarketBeat Staff
October 9, 2023

Key Points

  • Rapidly growing demand for Novo Nordisk’s GLP-1 diabetes and obesity treatments are fattening up its financial results.
  • Last month, the company completed a 2-for-1 stock split that put its price under $100.
  • Management raised full-year sales growth outlook to 27% to 33%, reflecting the company's massive market share in a pair of fast-growth markets.
  • 5 stocks we like better than Novo Nordisk A/S.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should you invest $1,000 in Novo Nordisk A/S right now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Novo Nordisk A/S (NVO)
4.2387 of 5 stars		$102.85-2.3%0.70%33.28Moderate Buy$144.50
Eli Lilly and Company (LLY)
4.9913 of 5 stars		$750.62-0.4%0.69%81.15Moderate Buy$1,007.94
Walmart (WMT)
4.79 of 5 stars		$88.32+1.3%0.94%36.25Moderate Buy$91.49
Mondelez International (MDLZ)
4.7914 of 5 stars		$64.76+0.5%2.90%22.96Buy$80.31
Nestlé (NSRGY)
0.7698 of 5 stars		$86.87-0.3%2.43%N/AReduceN/A
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

'Best Report in 2 Years': NVIDIA Earnings Crushes Expectations Again

'Best Report in 2 Years': NVIDIA Earnings Crushes Expectations Again

With revenue growth nearing 95%, margins widening, and earnings soaring 111%, this might be NVIDIA's most impressive performance yet.

Related Videos

How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide
NVIDIA Nears All-Time Highs: How High Can This AI Leader Climb?
What the Bulls and Bears Are Saying About NVIDIA Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines